c-MYB and DMTF1 in Cancer

Area of Science:

• Molecular biology
• Cancer research
• Genetics

Background:

• The c-Myb gene encodes a transcription factor crucial for cell regulation, frequently overexpressed in cancers like leukemia and breast cancer, indicating its oncogenic role.
• Specific chromosomal translocations lead to aberrant c-MYB fusion proteins in various human leukemias and carcinomas.
• Therapeutic strategies targeting c-Myb include antisense oligonucleotides and small molecule inhibitors disrupting its interactions.

Purpose of the Study:

• To discuss the significance of aberrant expression of c-Myb and Dmp1 (Dmtf1) proteins in human cancers.
• To explore the clinical implications of these transcription factors in cancer development and progression.

Main Methods:

• Review of literature on c-Myb and Dmp1 (Dmtf1) gene function and expression in human cancers.
• Analysis of the role of c-Myb in cell proliferation, differentiation, and apoptosis.
• Investigation of Dmp1's interaction with cyclin D2, p53, and its role in the p53 pathway.

Main Results:

• c-Myb is a proto-oncogene frequently overexpressed in human leukemias and solid tumors.
• Dmp1 (Dmtf1) functions as a transcription factor, interacts with p53, and its deletion is linked to longer survival in cancer patients.
• Aberrant expression patterns of both c-Myb and Dmp1 are significant in human cancers.

Conclusions:

• Both c-Myb and Dmp1 are critical transcription factors with significant roles in human oncogenesis.
• Understanding their aberrant expression and interactions provides insights into cancer mechanisms and potential therapeutic targets.